Dr. Roy E. Smith
Overview
Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. Dr Smith specializes in bleeding and thrombotic disorders, Rare Homologic Diseases, Chronic Leukemia and Myelodyplasia. Dr. Smith is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from The Ohio State University, Columbus, and his Master of Science degree from the University of Wisconsin, College of Medicine, Madison. He completed his residency in medical oncology and his fellowship in hematology oncology, both at The Ohio State University. He is the former director of the Ohio State University Hospital's Special Coagulation Laboratory and its Hemophilia Center. He presently serves as chairman of the Central Investigational Review Board for the Cancer Therapeutics and Development branch of the National Cancer Institute and has served on the Peripheral and Central Nervous System Drug Advisory Committee and the Oncologic Drug Advisory Committee of the FDA. Dr. Smith serves as the co-chair of the Anticoagulation Task Force for the Presbyterian Hospital and its affiliates and chair of the Anticoagulation Working Group of the system-wide P and T committee. Dr. Smith is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Society for Scientific Exploration, The International Society of Thrombosis and Hemostasis, the American Medical Association and the American Society for Apheresis, and the American College of Chest Physicians. He is a Fellow of the American College of Physicians and the International Academy of Clinical and Applied Thrombosis and Hemostasis.
Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Venous Thromboembolism (VTE), Acute Hepatic Porphyria (AHP), Shwartzman Phenomenon, and Porphyria.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3601 Fifth Ave, Falk Building, 3rd Floor, Pittsburgh, PA 15213
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Classical Hematology
Craig Seaman is a Hematologist in Pittsburgh, Pennsylvania. Dr. Seaman is rated as a Distinguished provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Von Willebrand Disease (VWD), Hemophilia A, Blood Clots, and Hemophilic Arthropathy. Dr. Seaman is currently accepting new patients.
Allegheny Clinic Medical Oncology
Ali Amjad is a Hematologist Oncology specialist and a Hematologist in New Castle, Pennsylvania. Dr. Amjad is rated as an Advanced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Vulvar Cancer, Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Splenectomy. Dr. Amjad is currently accepting new patients.
Butler Medical Providers
Alexander Barsouk is a Hematologist Oncology specialist and a Hematologist in Clarion, Pennsylvania. Dr. Barsouk is rated as a Distinguished provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Gastroesophageal Junction Cancer, and Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Hepatic Porphyria (AHP)Dr. Smith isAdvanced. Learn about Acute Hepatic Porphyria (AHP).
- PorphyriaDr. Smith isAdvanced. Learn about Porphyria.
- Pulmonary EmbolismDr. Smith isAdvanced. Learn about Pulmonary Embolism.
- Shwartzman PhenomenonDr. Smith isAdvanced. Learn about Shwartzman Phenomenon.
- ThrombocytopeniaDr. Smith isAdvanced. Learn about Thrombocytopenia.
- Venous Thromboembolism (VTE)Dr. Smith isAdvanced. Learn about Venous Thromboembolism (VTE).
- Experienced
- Acute Eosinophilic PneumoniaDr. Smith isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Adult Immune ThrombocytopeniaDr. Smith isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Smith isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Smith isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Smith isExperienced. Learn about Antiphospholipid Syndrome.
- Aplastic AnemiaDr. Smith isExperienced. Learn about Aplastic Anemia.